PRECIGEN, INC. Money Market Funds, at Carrying Value
PRECIGEN, INC. (PGEN) had Money Market Funds, at Carrying Value of $11.39 million as of 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Notes
us-gaap:MoneyMarketFundsAtCarryingValue · last filed 2023-08-09
- 2023-06-30: Money Market Funds, at Carrying Value $11.39M.
- 2023-03-31: Money Market Funds, at Carrying Value $5.63M.
- 2022-12-31: Money Market Funds, at Carrying Value $3.00K; Money Market Funds, at Carrying Value as first filed $2.98M.
- 2021-12-31: Money Market Funds, at Carrying Value $20.70M.
| Period end | Money Market Funds, at Carrying Value | Money Market Funds, at Carrying Value as first filed |
|---|---|---|
| 2023-06-30 | $11.39M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $5.63M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $3.00K 10-Q · filed 2023-08-09 | $2.98M 10-K · filed 2023-03-06 |
| 2021-12-31 | $20.70M 10-K · filed 2023-03-06 | |
| 2020-12-31 | $30.16M 10-K · filed 2022-03-01 | |
| 2019-12-31 | $47.24M 10-K · filed 2021-03-01 | |
| 2018-12-31 | $40.16M 10-K · filed 2020-03-02 | |
| 2017-12-31 | $43.01M 10-K · filed 2019-03-01 | |
| 2016-12-31 | $43.81M 10-K · filed 2018-03-01 | |
| 2015-12-31 | $112.78M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $93.16M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $87.47M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $87.77M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $16.60M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $18.72M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $67.79M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $93.37M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $43.73M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $56.69M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $28.86M 10-Q/A · filed 2013-10-21 | |
| 2012-12-31 | $9.38M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |